Which has higher valuation & earnings, MOTS or AFIB?

Motus GI has higher earnings, but lower revenue than Acutus Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Motus GI $319K 0.00 -$12.87M -$14.69 N/A Acutus Medical $7.16M 0.00 -$81.66M -$0.11 N/A

Do analysts prefer SSKN or MOTS?

Given Motus GI's higher possible upside, analysts plainly believe Motus GI is more favorable than Strata Skin Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Motus GI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings & valuation, UTRS or MOTS?

Motus GI has lower revenue, but higher earnings than Minerva Surgical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Minerva Surgical $51.69M 0.00 -$34.11M -$4.21 N/A Motus GI $319K 0.00 -$12.87M -$14.69 N/A

Is UTRS or MOTS more profitable?

Company Net Margins Return on Equity Return on Assets Minerva Surgical N/A N/A N/A Motus GI N/A N/A N/A

Which has better earnings & valuation, MOTS or DRTSW?

Alpha Tau Medical has lower revenue, but higher earnings than Motus GI. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Motus GI $319K 0.00 -$12.87M -$14.69 N/A Alpha Tau Medical N/A N/A N/A N/A N/A

Is MOTS or DRTSW more profitable?

Company Net Margins Return on Equity Return on Assets Motus GI N/A N/A N/A Alpha Tau Medical N/A N/A N/A

Which has better valuation and earnings, MOTS or ANZUW?

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Motus GI. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Motus GI $319K 0.00 -$12.87M -$14.69 N/A Anzu Special Acquisition Corp I N/A N/A N/A N/A N/A

Is MOTS or ANZUW more profitable?

Company Net Margins Return on Equity Return on Assets Motus GI N/A N/A N/A Anzu Special Acquisition Corp I N/A N/A N/A

Motus GI (MOTS) Competitors

Compare

MOTS vs. AFIB, SSKN, UTRS, DRTSW, and ANZUW

Should you buy Motus GI stock or one of its competitors? MarketBeat compares Motus GI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Motus GI include Acutus Medical (AFIB), Strata Skin Sciences (SSKN), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry.

How does Motus GI compare to Acutus Medical?

Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

20.1% of Motus GI shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Comparatively, 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Motus GI has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.67, indicating that its share price is 467% more volatile than the broader market.

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Motus GI	N/A	N/A	N/A
Acutus Medical	-272.74%	-311.64%	-11.57%

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company	Overall Sentiment
Motus GI	Neutral
Acutus Medical	Neutral

Motus GI has higher earnings, but lower revenue than Acutus Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Motus GI	$319K	0.00	-$12.87M	-$14.69	N/A
Acutus Medical	$7.16M	0.00	-$81.66M	-$0.11	N/A

Summary

Motus GI and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Motus GI compare to Strata Skin Sciences?

Strata Skin Sciences (NASDAQ:SSKN) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by insiders. Comparatively, 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Given Motus GI's higher possible upside, analysts plainly believe Motus GI is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Motus GI	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Strata Skin Sciences has higher revenue and earnings than Motus GI. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98M	0.00	-$10.09M	-$1.41	N/A
Motus GI	$319K	0.00	-$12.87M	-$14.69	N/A

Strata Skin Sciences has a beta of -0.05, indicating that its stock price is 105% less volatile than the broader market. Comparatively, Motus GI has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market.

Motus GI has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Motus GI's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
Motus GI	N/A	N/A	N/A

In the previous week, Strata Skin Sciences' average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company	Overall Sentiment
Strata Skin Sciences	Neutral
Motus GI	Neutral

Summary

Strata Skin Sciences and Motus GI tied by winning 6 of the 12 factors compared between the two stocks.

How does Motus GI compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

Motus GI has lower revenue, but higher earnings than Minerva Surgical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Minerva Surgical	$51.69M	0.00	-$34.11M	-$4.21	N/A
Motus GI	$319K	0.00	-$12.87M	-$14.69	N/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company	Overall Sentiment
Minerva Surgical	Neutral
Motus GI	Neutral

20.1% of Motus GI shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by insiders. Comparatively, 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Minerva Surgical has a beta of 2.92, meaning that its share price is 192% more volatile than the broader market. Comparatively, Motus GI has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Minerva Surgical	N/A	N/A	N/A
Motus GI	N/A	N/A	N/A

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Motus GI compare to Alpha Tau Medical?

Motus GI (NASDAQ:MOTS) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

Company	Net Margins	Return on Equity	Return on Assets
Motus GI	N/A	N/A	N/A
Alpha Tau Medical	N/A	N/A	N/A

In the previous week, Alpha Tau Medical had 3 more articles in the media than Motus GI. MarketBeat recorded 3 mentions for Alpha Tau Medical and 0 mentions for Motus GI. Alpha Tau Medical's average media sentiment score of 0.37 beat Motus GI's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Motus GI	Neutral
Alpha Tau Medical	Neutral

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Alpha Tau Medical has lower revenue, but higher earnings than Motus GI.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Motus GI	$319K	0.00	-$12.87M	-$14.69	N/A
Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A

Summary

Motus GI beats Alpha Tau Medical on 3 of the 5 factors compared between the two stocks.

How does Motus GI compare to Anzu Special Acquisition Corp I?

Motus GI (NASDAQ:MOTS) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

In the previous week, Anzu Special Acquisition Corp I had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Anzu Special Acquisition Corp I and 0 mentions for Motus GI. Anzu Special Acquisition Corp I's average media sentiment score of 0.87 beat Motus GI's score of 0.00 indicating that Anzu Special Acquisition Corp I is being referred to more favorably in the news media.

Company	Overall Sentiment
Motus GI	Neutral
Anzu Special Acquisition Corp I	Positive

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Motus GI.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Motus GI	$319K	0.00	-$12.87M	-$14.69	N/A
Anzu Special Acquisition Corp I	N/A	N/A	N/A	N/A	N/A

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Motus GI	N/A	N/A	N/A
Anzu Special Acquisition Corp I	N/A	N/A	N/A

Summary

Motus GI beats Anzu Special Acquisition Corp I on 3 of the 5 factors compared between the two stocks.

Get Motus GI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MOTS vs. The Competition

Export

Metric	Motus GI	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1K	$38.94M	$6.81B	$12.41B
Dividend Yield	N/A	1.08%	2.67%	9.39%
P/E Ratio	0.00	16.98	27.00	24.19
Price / Sales	N/A	26.05	517.85	93.08
Price / Cash	N/A	18.86	26.68	47.25
Price / Book	N/A	9.22	10.67	6.26
Net Income	-$12.87M	-$17.39M	$3.60B	$331.76M

Motus GI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MOTS Motus GI	N/A	N/A	N/A	N/A	$1K	$319K	N/A	30
AFIB Acutus Medical	N/A	$0.00 flat	N/A	N/A	$3K	$7.16M	N/A	340
SSKN Strata Skin Sciences	N/A	$0.00 -99.6%	N/A	N/A	$2K	$30.98M	N/A	120	Gap Down
UTRS Minerva Surgical	N/A	N/A	N/A	N/A	$1K	$51.69M	N/A	160
DRTSW Alpha Tau Medical	N/A	$3.55 +4.4%	N/A	+1,398.0%	$0.00	N/A	N/A	80	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MOTS) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Motus GI (MOTS) Competitors

MOTS vs. AFIB, SSKN, UTRS, DRTSW, and ANZUW

How does Motus GI compare to Acutus Medical?

Summary

How does Motus GI compare to Strata Skin Sciences?

Summary

How does Motus GI compare to Minerva Surgical?

Summary

How does Motus GI compare to Alpha Tau Medical?

Summary

How does Motus GI compare to Anzu Special Acquisition Corp I?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MOTS vs. The Competition

Motus GI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Motus GI (MOTS) Competitors

MOTS vs. AFIB, SSKN, UTRS, DRTSW, and ANZUW

How does Motus GI compare to Acutus Medical?

Do institutionals & insiders have more ownership in MOTS or AFIB?

Which has more volatility & risk, MOTS or AFIB?

Is MOTS or AFIB more profitable?

Does the media favor MOTS or AFIB?

Which has higher valuation & earnings, MOTS or AFIB?

Summary

How does Motus GI compare to Strata Skin Sciences?

Do insiders & institutionals hold more shares of SSKN or MOTS?

Do analysts prefer SSKN or MOTS?

Which has stronger valuation and earnings, SSKN or MOTS?

Which has more volatility and risk, SSKN or MOTS?

Is SSKN or MOTS more profitable?

Does the media prefer SSKN or MOTS?

Summary

How does Motus GI compare to Minerva Surgical?

Which has higher earnings & valuation, UTRS or MOTS?

Does the media favor UTRS or MOTS?

Do institutionals & insiders believe in UTRS or MOTS?

Which has more risk & volatility, UTRS or MOTS?

Is UTRS or MOTS more profitable?

Summary

How does Motus GI compare to Alpha Tau Medical?

Is MOTS or DRTSW more profitable?

Does the media favor MOTS or DRTSW?

Do insiders & institutionals believe in MOTS or DRTSW?

Which has better earnings & valuation, MOTS or DRTSW?

Summary

How does Motus GI compare to Anzu Special Acquisition Corp I?

Does the media prefer MOTS or ANZUW?

Which has better valuation and earnings, MOTS or ANZUW?

Do insiders and institutionals believe in MOTS or ANZUW?

Is MOTS or ANZUW more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MOTS vs. The Competition

Motus GI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools